insights_auto
Why is VLA down 2,11%?
Dive Deeperchevron_right
VLA:EPA
Valneva SE
€2,50
arrow_downward
-2,11%(-0,054) 1D
6 ພ.ຈ., 17 ໂມງ 35 ນາທີ 18 ວິນາທີ GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VLA...
Open
€2,58
High
€2,58
Low
€2,45
Mkt. cap
483,30 ລ້ານ
Avg. vol.
382,10 ພັນ
Volume
242,74 ພັນ
52-wk high
€5,15
52-wk low
€2,03
EPS
€-0,89
Shares outstanding
190,38 ລ້ານ
No. of employees
620
Open
€2,58
High
€2,58
Low
€2,45
Mkt. cap
483,30 ລ້ານ
Avg. vol.
382,10 ພັນ
Volume
242,74 ພັນ
52-wk high
€5,15
52-wk low
€2,03
EPS
€-0,89
Shares outstanding
190,38 ລ້ານ
No. of employees
620
News stories
From web sources and news partners
Idéal Investisseur
·
2 ມື້ກ່ອນ
Valneva shares up 17.5% over the quarter and among the leaders of the SBF 120
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE
CEOThomas Lingelbach
Employees620
Founded2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitevalneva.com